These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36743769)

  • 1. Alkaline pH in intracranial tuberculomas: A
    Jayakumar PN; Nagarajan K
    J Neurosci Rural Pract; 2022; 13(4):791-794. PubMed ID: 36743769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas.
    Gupta RK; Husain M; Vatsal DK; Kumar R; Chawla S; Husain N
    Magn Reson Imaging; 2002 Jun; 20(5):375-81. PubMed ID: 12206861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR spectroscopy of intracranial tuberculomas: A singlet peak at 3.8 ppm as potential marker to differentiate them from malignant tumors.
    Morales H; Alfaro D; Martinot C; Fayed N; Gaskill-Shipley M
    Neuroradiol J; 2015 Jun; 28(3):294-302. PubMed ID: 26246099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Multiparametric Magnetic Resonance Imaging of the Brain in Differentiating Neurocysticercosis From Tuberculoma.
    Joy L; Sakalecha AK
    Cureus; 2023 May; 15(5):e39003. PubMed ID: 37323306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
    Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
    Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI).
    Parry AH; Wani AH; Shaheen FA; Wani AA; Feroz I; Ilyas M
    Br J Radiol; 2018 Nov; 91(1091):20180342. PubMed ID: 29987985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric magnetic resonance imaging features of giant intracranial tuberculomas.
    Peer S; Tiwari S; Swaminathan AD; Jabeen S; Saini J; Prasad C; Kulanthaivelu K; Murumkar V; Vengalil S; Netravathi M; Nalini A; Raju S; Swaroop NS; Srinivas D
    Clin Neurol Neurosurg; 2021 Nov; 210():107006. PubMed ID: 34739879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of high dose irradiation on canine thigh muscle by follow-up magnetic resonance imaging and phosphorus-31 magnetic resonance spectroscopy.
    Choe BY; Jee WH; Suh TS; Lee HK; Shinn KS
    Invest Radiol; 1998 May; 33(5):300-7. PubMed ID: 9609489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo localized proton magnetic resonance spectroscopy of intracranial tuberculomas.
    Gupta RK; Poptani H; Kohli A; Chhabra DK; Sharma B; Gujral RB
    Indian J Med Res; 1995 Jan; 101():19-24. PubMed ID: 7883279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study.
    Patel N; Forton DM; Coutts GA; Thomas HC; Taylor-Robinson SD
    Metab Brain Dis; 2000 Sep; 15(3):223-40. PubMed ID: 11206591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton MR spectroscopy and diffusion-weighted MR imaging for the diagnosis of intracranial tuberculomas. Report of two cases.
    Kaminogo M; Ishimaru H; Morikawa M; Suzuki Y; Shibata S
    Neurol Res; 2002 Sep; 24(6):537-43. PubMed ID: 12238618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
    Mohan S; Verma A; Lim CC; Hui F; Kumar S
    Neuroradiol J; 2010 Jun; 23(3):269-78. PubMed ID: 24148583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative magnetic resonance techniques in the evaluation of intracranial tuberculomas.
    Vasudev MK; Jayakumar PN; Srikanth SG; Nagarajan K; Mohanty A
    Acta Radiol; 2007 Mar; 48(2):200-6. PubMed ID: 17354142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive study of brain tumours metabolism using phosphorus-31 magnetic resonance spectroscopy.
    Hnilicova P; Richterova R; Zelenak K; Kolarovszki B; Majercikova Z; Hatok J
    Bratisl Lek Listy; 2020; 121(7):488-492. PubMed ID: 32990002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of solitary pulmonary lesion: emphasis on tuberculomas and comparison with tumors.
    Chung MH; Lee HG; Kwon SS; Park SH
    J Magn Reson Imaging; 2000 Jun; 11(6):629-37. PubMed ID: 10862062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy status and metabolism in intracranial space occupying lesions: a prospective 31p spectroscopic study.
    Kamble RB; Peruvumba N J; Shivashankar R
    J Clin Diagn Res; 2014 Nov; 8(11):RC05-8. PubMed ID: 25584283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization transfer MR imaging correlation with histopathology in intracranial tuberculomas.
    Gupta RK; Husain N; Kathuria MK; Datta S; Rathore RK; Husain M
    Clin Radiol; 2001 Aug; 56(8):656-63. PubMed ID: 11467867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.